|
|
cell surface pattern recognition receptor signaling pathway
|
GO:0002752 |
2 |
0.790
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.677
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.656
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.600
|
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.555
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.551
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
47 |
0.544
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.529
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.515
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.478
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.474
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.472
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.434
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.431
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.429
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.416
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.414
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.381
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.326
|
|
|
|
response to molecule of fungal origin
|
GO:0002238 |
4 |
0.323
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.311
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.306
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.294
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.292
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.292
|
|
|
|
innate immune response activating cell surface receptor signaling pathway
|
GO:0002220 |
4 |
0.291
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.284
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.278
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.266
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.263
|
|
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
25 |
0.253
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.233
|
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.222
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.216
|
|
|
|
stimulatory c type lectin receptor signaling pathway
|
GO:0002223 |
2 |
0.214
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.201
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.185
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.178
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.177
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.174
|
|
|
|
response to interferon beta
|
GO:0035456 |
22 |
0.172
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.172
|
|
|
|
cellular response to interferon beta
|
GO:0035458 |
21 |
0.167
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.164
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.161
|
|
|
|
negative regulation of type i hypersensitivity
|
GO:0001811 |
1 |
0.160
|
|
|
|
cellular response to interferon alpha
|
GO:0035457 |
4 |
0.158
|
|
|
|
interferon beta production
|
GO:0032608 |
16 |
0.158
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.155
|
|
|
|
positive regulation of cytokine biosynthetic process
|
GO:0042108 |
40 |
0.154
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.153
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.151
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.149
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.146
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.144
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.143
|
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.133
|
|
|
|
natural killer cell mediated immunity
|
GO:0002228 |
29 |
0.130
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.127
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.126
|
|
|
|
response to host
|
GO:0075136 |
3 |
0.118
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.116
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.116
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.112
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.111
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.110
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.110
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.109
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.108
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.107
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.107
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.106
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.103
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.101
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.101
|
|
|
|
positive regulation of t cell costimulation
|
GO:2000525 |
2 |
0.100
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.096
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.096
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.096
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.095
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.095
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.094
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.093
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.090
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.090
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.088
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.088
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.087
|
|
|
|
detection of fungus
|
GO:0016046 |
2 |
0.087
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.087
|
|
|
|
interferon beta biosynthetic process
|
GO:0045350 |
4 |
0.086
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.086
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.086
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.083
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.082
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.081
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.081
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.081
|
|
|
|
negative regulation of viral transcription
|
GO:0032897 |
3 |
0.078
|
|
|
|
cd8 positive alpha beta t cell proliferation
|
GO:0035740 |
1 |
0.078
|
|
|
|
response to type i interferon
|
GO:0034340 |
12 |
0.077
|
|
|
|
toll like receptor 7 signaling pathway
|
GO:0034154 |
4 |
0.077
|
|
|
|
regulation of defense response to virus
|
GO:0050688 |
18 |
0.074
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.074
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.074
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.073
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.072
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.072
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.071
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.069
|
|
|
|
eosinophil activation
|
GO:0043307 |
1 |
0.069
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.068
|
|
|
|
regulation of defense response to virus by host
|
GO:0050691 |
8 |
0.068
|
|
|
|
type i interferon signaling pathway
|
GO:0060337 |
10 |
0.067
|
|
|
|
regulation of interferon beta production
|
GO:0032648 |
13 |
0.066
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.066
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.065
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.065
|
|
|
|
positive regulation of immunological synapse formation
|
GO:2000522 |
1 |
0.065
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.064
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.064
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.063
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.063
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.063
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.062
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.061
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.061
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.060
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.058
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.058
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.058
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.058
|
|
|
|
regulation of cytokine biosynthetic process
|
GO:0042035 |
59 |
0.057
|
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
25 |
0.057
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.057
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.056
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.055
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.054
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.054
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.054
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.054
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.053
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.053
|
|
|
|
negative regulation of eosinophil degranulation
|
GO:0043310 |
1 |
0.053
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.053
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.053
|
|
|
|
interleukin 18 production
|
GO:0032621 |
4 |
0.053
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.053
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.052
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.051
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.051
|
|
|
|
eosinophil degranulation
|
GO:0043308 |
1 |
0.051
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.051
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.050
|
|
|
|
toll like receptor signaling pathway
|
GO:0002224 |
38 |
0.050
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.049
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.048
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.048
|
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
25 |
0.048
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.048
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.048
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.048
|
|
|
|
positive regulation of cd8 positive alpha beta t cell extravasation
|
GO:2000451 |
2 |
0.047
|
|
|
|
positive regulation of type i interferon mediated signaling pathway
|
GO:0060340 |
4 |
0.047
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.046
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.046
|
|
|
|
cellular response to molecule of fungal origin
|
GO:0071226 |
2 |
0.046
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.046
|
|
|
|
defense response to protozoan
|
GO:0042832 |
25 |
0.045
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.045
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.045
|
|
|
|
tumor necrosis factor biosynthetic process
|
GO:0042533 |
10 |
0.045
|
|
|
|
negative regulation of toll like receptor signaling pathway
|
GO:0034122 |
14 |
0.045
|
|
|
|
regulation of natural killer cell activation
|
GO:0032814 |
22 |
0.044
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.044
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.043
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.043
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.043
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.043
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.043
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.043
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.043
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.043
|
|
|
|
cellular response to type i interferon
|
GO:0071357 |
10 |
0.043
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.043
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.042
|
|
|
|
nitric oxide biosynthetic process
|
GO:0006809 |
25 |
0.042
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.042
|
|
|
|
schwann cell proliferation
|
GO:0014010 |
2 |
0.042
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.041
|
|
|
|
positive regulation of t cell extravasation
|
GO:2000409 |
2 |
0.041
|
|
|
|
cytoplasmic pattern recognition receptor signaling pathway
|
GO:0002753 |
10 |
0.041
|
|
|
|
positive regulation of type i interferon production
|
GO:0032481 |
14 |
0.041
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.041
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.041
|
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.041
|
|
|
|
regulation of t cell costimulation
|
GO:2000523 |
2 |
0.041
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.040
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.040
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.040
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.040
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.040
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.039
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.039
|
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
29 |
0.039
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.039
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.039
|
|
|
|
positive regulation of platelet activation
|
GO:0010572 |
5 |
0.039
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.039
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.039
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.038
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.038
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.038
|
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
31 |
0.038
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.038
|
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.038
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.037
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.037
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.036
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.036
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.036
|
|
|
|
negative regulation of viral genome replication
|
GO:0045071 |
10 |
0.036
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.036
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.036
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.036
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.035
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.035
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.035
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.034
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.034
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.034
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.034
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.034
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.034
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.034
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.034
|
|
|
|
entry into cell of other organism involved in symbiotic interaction
|
GO:0051806 |
15 |
0.034
|
|
|
|
cellular response to bacterial lipopeptide
|
GO:0071221 |
3 |
0.034
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.034
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.033
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.033
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.033
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.033
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.033
|
|
|
|
cellular response to peptidoglycan
|
GO:0071224 |
4 |
0.033
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.033
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.032
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.032
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.032
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.032
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.032
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.032
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.032
|
|
|
|
alpha beta t cell proliferation
|
GO:0046633 |
21 |
0.032
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.032
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.032
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.031
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.031
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.031
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.031
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.031
|
|
|
|
macrophage differentiation
|
GO:0030225 |
20 |
0.031
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.031
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.031
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.031
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.031
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.031
|
|
|
|
type i interferon production
|
GO:0032606 |
29 |
0.031
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.030
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.030
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.030
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.030
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.030
|
|
|
|
modulation by symbiont of defense related host nitric oxide production
|
GO:0052163 |
1 |
0.030
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.030
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.030
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.030
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.030
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.029
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.029
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.029
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.029
|
|
|
|
regulation of type 2 immune response
|
GO:0002828 |
18 |
0.029
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.029
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.028
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.028
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.028
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.028
|
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.028
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.028
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.028
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.028
|
|
|
|
positive regulation of coagulation
|
GO:0050820 |
13 |
0.028
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.028
|
|
|
|
regulation of interferon beta biosynthetic process
|
GO:0045357 |
4 |
0.028
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.028
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.028
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.028
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.028
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.027
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.027
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.027
|
|
|
|
viral transcription
|
GO:0019083 |
3 |
0.027
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.027
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.027
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.027
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.026
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.026
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.026
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.026
|
|
|
|
positive regulation of interleukin 18 production
|
GO:0032741 |
2 |
0.026
|
|
|
|
positive regulation of hematopoietic stem cell migration
|
GO:2000473 |
1 |
0.026
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.026
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.026
|
|
|
|
regulation of interleukin 4 biosynthetic process
|
GO:0045402 |
3 |
0.026
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.026
|
|
|
|
toxin transport
|
GO:1901998 |
38 |
0.026
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.026
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.026
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.026
|
|
|
|
regulation of nlrp3 inflammasome complex assembly
|
GO:1900225 |
4 |
0.026
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.026
|
|
|
|
helper t cell chemotaxis
|
GO:0035704 |
1 |
0.026
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.025
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.025
|
|
|
|
negative regulation of macrophage apoptotic process
|
GO:2000110 |
3 |
0.025
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.025
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.025
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.025
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.025
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.025
|
|
|
|
positive regulation by symbiont of defense related host nitric oxide production
|
GO:0052347 |
1 |
0.025
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.025
|
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.025
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.025
|
|
|
|
t helper 17 cell chemotaxis
|
GO:0035705 |
1 |
0.025
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.025
|
|
|
|
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation
|
GO:2000526 |
1 |
0.024
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.024
|
|
|
|
mast cell proliferation
|
GO:0070662 |
4 |
0.024
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.024
|
|
|
|
regulation of nitric oxide biosynthetic process
|
GO:0045428 |
18 |
0.024
|
|
|
|
negative regulation of nlrp3 inflammasome complex assembly
|
GO:1900226 |
2 |
0.024
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.024
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.024
|
|
|
|
regulation of cd8 positive alpha beta t cell proliferation
|
GO:2000564 |
1 |
0.024
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.024
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.024
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.024
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.024
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.024
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.024
|
|
|
|
regulation of chemokine production
|
GO:0032642 |
30 |
0.024
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.024
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.024
|
|
|
|
negative regulation of hypersensitivity
|
GO:0002884 |
3 |
0.024
|
|
|
|
myeloid dendritic cell differentiation
|
GO:0043011 |
16 |
0.024
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.024
|
|
|
|
positive regulation of b cell activation
|
GO:0050871 |
49 |
0.023
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.023
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.023
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.023
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.023
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.023
|
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.023
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.023
|
|
|
|
positive regulation of natural killer cell mediated cytotoxicity
|
GO:0045954 |
16 |
0.023
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.023
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.023
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.023
|
|
|
|
regulation of interferon alpha production
|
GO:0032647 |
5 |
0.023
|
|
|
|
positive regulation of b cell proliferation
|
GO:0030890 |
24 |
0.022
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.022
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.022
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.022
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.022
|
|
|
|
regulation of granulocyte chemotaxis
|
GO:0071622 |
17 |
0.022
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.022
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.022
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.022
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.022
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.022
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.021
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.021
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.021
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.021
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.021
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.021
|
|
|
|
microglial cell activation
|
GO:0001774 |
3 |
0.021
|
|
|
|
positive regulation of nucleotide binding oligomerization domain containing 2 signaling pathway
|
GO:0070434 |
2 |
0.021
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.021
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.021
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.021
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.021
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.021
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.021
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.021
|
|
|
|
positive regulation of interferon beta biosynthetic process
|
GO:0045359 |
3 |
0.021
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.021
|
|
|
|
negative regulation of b cell proliferation
|
GO:0030889 |
13 |
0.021
|
|
|
|
regulation of platelet activation
|
GO:0010543 |
17 |
0.021
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.021
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.021
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.021
|
|
|
|
cd8 positive alpha beta t cell extravasation
|
GO:0035697 |
3 |
0.021
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.021
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.021
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.020
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.020
|
|
|
|
myd88 dependent toll like receptor signaling pathway
|
GO:0002755 |
7 |
0.020
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.020
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.020
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.020
|
|
|
|
mast cell activation
|
GO:0045576 |
27 |
0.020
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.020
|
|
|
|
regulation of immunoglobulin mediated immune response
|
GO:0002889 |
37 |
0.020
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.020
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.020
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.020
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.020
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.020
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.020
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.020
|
|
|
|
induction by organism of immune response of other organism involved in symbiotic interaction
|
GO:0052558 |
1 |
0.020
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.020
|
|
|
|
regulation of toll like receptor signaling pathway
|
GO:0034121 |
20 |
0.020
|
|
|
|
regulation of nucleotide binding oligomerization domain containing 1 signaling pathway
|
GO:0070428 |
3 |
0.020
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.020
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.019
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.019
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.019
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.019
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.019
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.019
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.019
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.019
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.019
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
22 |
0.019
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.019
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.019
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.019
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.019
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.019
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.019
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.019
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.019
|
|
|
|
regulation of dendritic cell chemotaxis
|
GO:2000508 |
1 |
0.019
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.019
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.019
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.019
|
|
|
|
positive regulation of actin nucleation
|
GO:0051127 |
3 |
0.019
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.019
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.018
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.018
|
|
|
|
type i interferon biosynthetic process
|
GO:0045351 |
9 |
0.018
|
|
|
|
regulation of t cell extravasation
|
GO:2000407 |
3 |
0.018
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.018
|
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
38 |
0.018
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.018
|
|
|
|
regulation of toll like receptor 9 signaling pathway
|
GO:0034163 |
3 |
0.018
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.018
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.018
|
|
|
|
hair follicle cell proliferation
|
GO:0071335 |
3 |
0.018
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.018
|
|
|
|
chemokine mediated signaling pathway
|
GO:0070098 |
17 |
0.018
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.018
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.018
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.018
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.018
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.018
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.018
|
|
|
|
positive regulation of hemostasis
|
GO:1900048 |
10 |
0.018
|
|
|
|
modulation by symbiont of host defense response
|
GO:0052031 |
1 |
0.018
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.018
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.018
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.018
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.018
|
|
|
|
positive regulation of granulocyte macrophage colony stimulating factor biosynthetic process
|
GO:0045425 |
2 |
0.018
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.018
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.018
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.018
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.018
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.018
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.017
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.017
|
|
|
|
positive regulation by symbiont of host defense response
|
GO:0052509 |
1 |
0.017
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.017
|
|
|
|
response to immune response of other organism involved in symbiotic interaction
|
GO:0052564 |
3 |
0.017
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.017
|
|
|
|
pyrimidine containing compound catabolic process
|
GO:0072529 |
3 |
0.017
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.017
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.017
|
|
